
Loading, please wait...

Loading, please wait...

Erdheim-Chester disease (ECD) is a multisystemic histiocytic neoplasm often identified by skeletal and visceral involvement. However, recent medical literature emphasizes the importance of recognizing atypical Erdheim-Chester disease skin lesions. Specifically, some patients develop glomeruloid haemangiomas and extensive angiomas. These lesions occur even when the classic features of POEMS syndrome are absent. Investigators have linked these findings to markedly elevated levels of vascular endothelial growth factor-A (VEGF-A).
Research demonstrates that MAPK-activated histiocytes drive these skin changes through a paracrine mechanism. Molecular analyses show that the histiocytes themselves harbor the activating mutations rather than the endothelial cells. Consequently, these histiocytes secrete VEGF-A, which stimulates localized blood vessel growth. This unique pathway explains why vascular proliferations appear in these patients. Furthermore, this mechanism differentiates these lesions from those caused by intrinsic vascular mutations.
Notably, the presence of glomeruloid haemangiomas often suggests POEMS syndrome. However, in the context of ECD, these lesions emerge due to systemic cytokine elevations. Clinicians should therefore screen patients with atypical vascular lesions for underlying histiocytic disorders. Treatment often targets the underlying MAPK pathway using BRAF or MEK inhibitors. Monitoring VEGF-A levels may also provide insight into disease activity and treatment response.
The most common skin findings are periorbital xanthelasma-like lesions. However, atypical vascular lesions like glomeruloid haemangiomas can occur due to high VEGF-A levels.
Histiocytes with MAPK mutations produce VEGF-A. This factor acts on nearby blood vessels to cause abnormal proliferation, leading to angiomas in the skin.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Recent studies reveal that Erdheim-Chester disease can manifest as glomeruloid haemangiomas driven by elevated VEGF-A levels. This discovery highlights a paracrine mechanism involving MAPK-activated histiocytes, providing new insights into the atypical cutaneous manifestations of this rare histiocytic neoplasm.
last month

Researchers at Kyushu University have uncovered a novel compound, lipoic acid trisulfide (LASSS), that enhances hepatocyte growth factor (HGF) signaling and protects against nitration-induced protein dysfunction, presenting a potential breakthrough for age-related muscle atrophy and sarcopenia.
Yesterday

A study identifies a critical hypospadias gene-environment interaction. Research shows that the risk gene DNAH8 and DEHP exposure combine to disrupt steroidogenesis and mesenchymal progenitor cell differentiation, significantly increasing the risk of severe urethral malformations in male fetuses.
5 days back

A pre-clinical study reveals that elevated serum pro-N-cadherin levels correlate strongly with severe cardiac fibrosis and diastolic dysfunction following radiation exposure, promising a potential early biomarker for radiation-related heart disease.
3 days back

Discover how biophysical forces shape tissue formation and regeneration. This review explores mechanotransduction in tissue development, from molecular sensors like integrins to tissue-scale flows, highlighting critical implications for regenerative medicine and functional organoid engineering.
Last week

A groundbreaking study utilizes single-cell RNA sequencing to map the tumor microenvironment of ovarian steroid cell tumors-not otherwise specified (SCT-NOS), identifying key steroidogenic subtypes and immune cell distributions that drive hyperandrogenism and tumor progression.
Last week